Option chain shows key data for IM Cannabis's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for IM Cannabis.

IM Cannabis (NASDAQ:IMCC) Stock, Option Chain

IM Cannabis

IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.

pexels-kindelmedia-7668047(1)

Cannabis

Earnings

News

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CSE:IMCC

IMCC

TSX:WEED

TSX:XLY

WEED

Select Sector SPDR-Consumer Discretionary

Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC) a medical cannabis company with operations in Israel and Germany, will report operational and financial results for the third quarter ended Sept. 30 on Nov. 14, 2024, before the market opens. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its third quarter ended Sept. 30 on Friday, Nov. 8, 2024, before the financial markets open.

Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?

ben-rosett-WdJkXFQ4VHY-unsplash(1)

Entrepreneurship

Movers & Shakers

AYRWF

CRLBF

CSE:AYR

CSE:CL

CSE:OILS

EDXC

FLGC

OILFF

ROMJF

SNDL

TILT

TLLTF

TSX:ACB

TSX:ROMJ

TSXV:ROMJ

The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York&#39;s chief equity officer at the state Office of Cannabis Management, Damian Fagon, has formally resigned, effective November 27.

The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About

elsa-olofsson-ZYEk3w9q2DM-unsplash

Financing

Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through the sale of roughly 625,000 units. What Happened: Each unit will be comprised of one share and one share purchase warrant, with each warrant entitling the holder to acquire one additional share at a price equal to a 50% premium to the offering price before the second anniversary of the closing date. The company plans to close the offering in one or more tranches. It will be led by the company&#39;s management team, including Oren Shuster, CEO and chairman of the board of directors and Shmulik Arbel, a director of the company.  

IM Cannabis&#39; $1.6M Non-Brokered Private Placement Offering, Here&#39;s What Investors Need To Know

IM Cannabis Corp

IM Cannabis reports Q2 results

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a player in the cannabis market, is refocusing its efforts by exiting the Ca...

IM Cannabis Corp: Strategic Refocus Amidst Challenges

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a leader in the medical cannabis sector, has enhanced its board of directors...

IM Cannabis Strengthens Board with Finance Expert

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. (IMCC) has appointed Shmulik Arbel to its board of directors and is refocusin...

IM Cannabis Corp Refocuses Strategy Amidst Expansion

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. reported a substantial 50% revenue growth in Q3 2024 for its German subsidiar...

IM Cannabis Corp. Sees Soaring Q3 Growth in Germany

IM Cannabis announces $1.61M private placement offering

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp. has announced a planned private placement offering aimed at raising up to US$...

IM Cannabis Corp. Plans Private Placement and Restructures Incentives

Tilray Q1 Preview: Germany Could Drive Earnings Surprise

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp reported a significant 50% increase in revenue in its German subsidiary follow...

IM Cannabis Corp: Revenue Surge and Expansion Plans

IM Cannabis Corp (TSE:IMCC) has released an update. IM Cannabis Corp., a prominent player in the medical cannabis market in Israel and Germany, is ...

IM Cannabis to Announce Q3 2024 Financial Results

TLRY

Press Releases

IM Cannabis Receives NASDAQ Notification of Regaining Compliance with Nasdaq's Minimum Bid Price Requirement

IM Cannabis to Report Second Quarter 2024 Financial Results on Wednesday, August 14th at 9:00am ET

IM Cannabis Reports Second Quarter Financial Results

Small Cap

IM Cannabis Announces Appointment of Shmulik Arbel to Board of Directors

Mutual Funds

Markets

IMC Germany Announces Outstanding Preliminary Q3, 2024 Performance with 50% Growth Over Q2

Offerings

IM Cannabis Announces up to US$1,613,000 Private Placement Offering Led by Management

IM Cannabis to Report Third Quarter 2024 Financial Results on Thursday, November 14th at 9:00am ET

IM Cannabis Closes Non-Brokered Private Placement led by Management and Concurrent Debt Settlement

Comments

IM Cannabis

IM Cannabis (IMCC) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga